NetworkNewsBreaks – Forty Seven, Inc. (NASDAQ: FTSV) Secures $86.3 Million in Underwritten Public Offering
Forty Seven (NASDAQ: FTSV), a clinical stage immuno-oncology company, has closed an underwritten public offering of 10,781,250 shares of its common stock, which includes 1,406,250 additional shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, the offering resulted in gross proceeds of approximately $86.3 million to Forty Seven, Inc., with each of the shares sold at the public offering price of $8.00. ROTH Capital Partners acted as co-manager for the offering. To view the full press release, visit http://nnw.fm/yMP0J About Forty Seven, Inc. Forty Seven, Inc. is a clinical-stage immuno-oncology company that…







